Oždian Tomáš Ph.D.
Journals
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
Nature.
2017,
552(7684),
194-199,
ISSN: 0028-0836,
PMID: 29211715,
Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells.
Journal of Proteomics.
2017,
162,
73-85,
ISSN: 1874-3919,
PMID: 28478306,
Synthesis and Cytostatic and Antiviral Profiling of Thieno-Fused 7-Deazapurine Ribonucleosides.
Journal of Medicinal Chemistry.
2017,
60(6),
2411-2424,
ISSN: 0022-2623,
PMID: 28221790,
Master mentorship
Brožová Klára
Optimization and validation of FGF23 protein assay in FFPE samples
Status:
Graduated from 2018 to 2020.
Hamerníková Barbora
Proteomic discovery of endometrial receptivity biomarker
Status:
Graduated from 2021 to 2023.
Bachelor mentorship
Plisková Magdalena
Optimization of elution of cervical smear proteins from different sampling sets
Status:
Ongoing from 2023.
Mihoková Frederika
Proteomic characteristics of seminal plasma in obstructive and non-obstructive azoospermia
Status:
Graduated from 2021 to 2022.
Kalábová Pavlína
The validation of differentially expressed proteins in CCRF-CEM cell line treated by oxaliplatin
Status:
Graduated from 2013 to 2014.
Open positions
Project: | Omics Approaches in Reproductive Medicine |
---|---|
Supervisors: | Oždian Tomáš Ph.D., Dostál Jiří |
Available: | 2 |
Intended for: | Doctoral training |